PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'Institute of Microbiology and Virology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.\', \'Department of Internal Medicine, Israelitic Hospital, Hamburg, Germany.\', \'German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Braunschweig, Germany.\', \'Department of Medicine, Hematology, Oncology, Gastroenterology and Infectious Diseases, Klinikum Esslingen, Esslingen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0258450
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34941875
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all